Skip Navigation


NDT Advance Access first published online on January 5, 2008
This version published online on January 10, 2008

Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfm828
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
23/5/1621    most recent
gfm828v2
gfm828v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Yilmaz, M. I.
Right arrow Articles by Axelsson, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yilmaz, M. I.
Right arrow Articles by Axelsson, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org



Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin

Mahmut Ilker Yilmaz1,2, Mutlu Saglam3, Abdul Rashid Qureshi2, Juan Jesus Carrero2, Kayser Caglar1, Tayfun Eyileten1, Alper Sonmez4, Erdinc Cakir5, Yusuf Oguz1, Abdulgaffar Vural1, Mujdat Yenicesu1, Peter Stenvinkel2, Bengt Lindholm2 and Jonas Axelsson2

1 Nephrology Department of Gülhane School of Medicine, Etlik-Ankara, Turkey 2 Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention, and Technology, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden 3 Radiology Department of Gülhane School of Medicine, Turkey 4 Internal Medicine Department of Gülhane School of Medicine, Turkey 5 Biochemistry Department of Gülhane School of Medicine, Etlik-Ankara, Turkey

Correspondence and offprint requests to: Mahmut Ilker Yilmaz, Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, K56 Karolinska University Hospital Huddinge, 141 86 Stockholm, Sweden. Tel: +46-8-58582532; Fax: +46-8-58582532; E-mail: mahmutiyilmaz{at}yahoo.com



  Abstract

Background. Type-2 diabetes and diabetic kidney disease have additive effects on cardiovascular risk. Furthermore, the degree of proteinuria is an independent predictor of mortality in this patient group. We hypothesized that altered kidney clearance and/or metabolism of vasoactive peptides occurring during proteinuria could link early diabetic nephropathy to cardio vascular disease (CVD).

Methods. We performed a cross-sectional study of 85 incident patients (51 ± 5 years, 49 males) with type-2 diabetes and 38 age- and sex-matched controls. We further divided patients by the presence of minor (<500 mg/day; n = 40) or severe (≥500 mg/day; n = 45) proteinuria. Clinical and anthropometric data, along with ultrasonographic flow-mediated dilatation (FMD) of the brachial artery and carotid intima-media thicknesses (CIMT), were recorded in each group. Circulating NAMPT/visfatin, adiponectin (normalized to BMI), AHSG/fetuin-A and hsCRP levels were also measured using commercial ELISA.

Results. Plasma NAMPT/visfatin, CIMT, HOMA index and hsCRP levels were all significantly higher in diabetics than in control subjects, and all but CIMT correlated with proteinuria ({rho} = 0.46; P < 0.001, {rho} = 0.54; P > 0.05, {rho} = 0.32; P = 0.003, {rho} = 0.76; P < 0.001, respectively). FMD, adiponectin and AHSG/fetuin-A levels were significantly lower, and negatively correlated with proteinuria ({rho} = –0.54; P < 0.001, {rho} = –0.56; P < 0.001, {rho} = –0.48; P < 0.001, respectively). In a multivariate regression analysis, the degrees of proteinuria (r2 = –0.32, P = 0.04) and plasma levels of NAMPT/visfatin (r2 = –0.33, P = 0.006) were independently related to FMD.

Conclusions. The present study suggests that the presence of proteinuria, regardless of the degree of renal function impairment, is an important predictor of endothelial dysfunction in early diabetic nephropathy and that it is associated with altered circulating levels of NAMPT/visfatin and adiponectin.

Keywords: albuminuria; CVD; fetuin-A; NAMPT/visfatin; PBEF-1

Received for publication: 14. 7.07
Accepted in revised form: 24.10.07


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
N. G. Abraham, J. Cao, D. Sacerdoti, X. Li, and G. Drummond
Heme oxygenase: the key to renal function regulation
Am J Physiol Renal Physiol, November 1, 2009; 297(5): F1137 - F1152.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
K.-D. Nusken, M. Petrasch, M. Rauh, W. Stohr, E. Nusken, H. Schneider, and J. Dotsch
Active visfatin is elevated in serum of maintenance haemodialysis patients and correlates inversely with circulating HDL cholesterol
Nephrol. Dial. Transplant., September 1, 2009; 24(9): 2832 - 2838.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. Axelsson
The emerging biology of adipose tissue in chronic kidney disease: from fat to facts
Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3041 - 3046.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.